Ocular Genomics
243 Charles Street Boston, MA 02114 Contact us
Diagnostic Testing
Support our research
Explore our labs
Ocular Genomics MENU
Ocular Genomics
  • Meet the Team
  • Services
    • Biobank Core Services
    • Bioinformatics and Statistics Core
    • Functional Genomics (Zebrafish) Core
    • Gene Transfer Vector
      • Rates
      • Order Information
      • Contact Us
    • Genetic Diagnostic Testing Service
      • Pricing
    • Genomics Core Services
      • Additional Genomics Services
      • Sanger Sequencing
      • Array Analysis
      • Next-Generation Sequencing (NGS)
  • Labs
    • Biobank Core
    • Bujakowska Lab
      • Lab Members
      • Publications
    • Comander Lab
      • Lab Members
      • Publications
    • Engle Lab
    • Functional Genomics Core (Zebrafish Facility)
      • Lab Members
    • Genetic Counseling Team
      • Team Members
    • Genomics Core Lab
      • Lab Members
    • Liu Lab
      • Lab Members
      • Publications
      • Projects
    • MEEI Bioinformatics Center (MBC)
      • Lab Members
    • Pierce Lab
      • Lab Members
      • Publications
      • Projects
    • Segrè Lab
      • Selected Publications
    • Vandenberghe Lab
      • Lab Members
    • Wiggs Lab
      • Lab Members
    • Mary Whitman
      • Lab Members
    • iPS Research Lab
      • Lab Members
      • Grant support
      • Publications
  • News & Publications
    • RETINAL Transcriptome
  • Affiliates
  • Careers
  • Home
  • News
  • Vandenberghe Lab working on SARS-CoV2 vaccine

Recent Posts

  • Network Analysis predicts IRDs
  • Natural History of RP: new findings
  • Ocular Trauma during COVID-19 pandemic
  • JAMA Ophthalmol Ramo 2023
  • OGI iPS Special Seminar

Archives

  • July 2023
  • June 2023
  • May 2023
  • March 2023
  • February 2023
  • November 2022
  • June 2021
  • May 2021
  • March 2021
  • February 2021
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • June 2020
  • August 2019
  • May 2019
  • April 2019
  • May 2018
  • April 2018
  • March 2018
  • November 2017
  • September 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017

Categories

  • News
  • Publication

Vandenberghe Lab working on SARS-CoV2 vaccine
June 15, 2020

Luk Vandenberghe PhD, Assistant Director of the Ocular Genomics Institute, Director of the Grousbeck Gene Therapy Center at Massachusetts Eye and Ear, and Associate Professor of Ophthalmology at Harvard Medical School is leading the work at Massachusetts Eye and Ear and Massachusetts General Hospital in the development of an experimental vaccine called AAVCOVID, a novel gene-based vaccine candidate against SARS-CoV2, the virus that causes COVID-19. This strategy uses the FDA-approved gene transfer technology, the adeno-associated viral (AAV) vector, to deliver genetic sequences of the SARS-CoV-2 Spike antigen so the body can develop an immune response to the coronavirus. It is currently in preclinical development with a plan to begin clinical testing in humans later this year.

Read some of the press coverage on the AAVCOVID project here:

Two Boston Hospitals Team Up In ‘Urgent’ Race To Create Coronavirus Vaccine

Massachusetts Eye and Ear Announces Promising Gene-Based COVID-19 Vaccine

A Coronavirus Vaccine Project Takes a Page from Gene Therapy

Featured:

Contact Us

243 Charles Street
Boston, MA 02114

Labs

  • Engle Lab
  • Pierce Lab
  • Vandenberghe Lab
  • Wiggs Lab
  • Genomics Core Lab
  • Functional Genomics Core (Zebrafish Facility)
  • MEEI Bioinformatics Center (MBC)

Sitemap

  • Affiliates
  • Careers
  • Meet the Team
  • News & publications
  • Support Our Research
  • Services
  • Privacy
website-boston WebsiteBoston